Atorvastatin + Ezetimibe Tablet

Atorvastatin + Ezetimibe Tablet
Product Description

Dasan Pharmaceutical’s Atorvastatin + Ezetimibe Tablet is a high-performance fixed-dose combination (FDC) therapy engineered for comprehensive and dual-mechanism lipid management. By integrating a potent HMG-CoA reductase inhibitor (Statin) with a selective cholesterol absorption inhibitor, this product utilizes our advanced particle engineering to deliver exceptional chemical stability and synchronized dissolution profiles. It offers an efficient, marketplace-ready solution for global pharmaceutical partners looking to enhance their cardiovascular and metabolic disease portfolios.

DASAN Pharmaceutical Co., Ltd

  • Country/Region:
    Korea, Republic Of
  • Founded:
    1996
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Custom Manufacturing/Custom Synthesis
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Strength: 10mg+10mg, 20mg+10mg, 40mg+10mgStability Study: Zone II & Zone IVb
    Package: Blister
  • Selling Points
    Dual-Mechanism Synergistic Stability: Leverages advanced multi-layer tableting or specialized co-granulation technologies to effectively prevent physical and chemical interactions between Atorvastatin and Ezetimibe, ensuring maximum product shelf life.

    Maximizing Poor Solubility (Ezetimibe Optimization): Incorporates precision solubilization and particle-size reduction technologies to dramatically boost the dissolution rate of poorly soluble Ezetimibe, achieving flawless bioequivalence matching global standards.

    Excellent Processing Profile for High-Speed Tableting: Engineered to overcome tablet capping, sticking, or weight variations during automated processes, maintaining pristine tablet appearance and ideal hardn...

  • Supplied from
    Korea, Republic Of

DASAN Pharmaceutical Co., Ltd

  • Country/Region:
    Korea, Republic Of
  • Founded:
    1996
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Custom Manufacturing/Custom Synthesis
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from DASAN Pharmaceutical Co., Ltd (2)

  • Global Customized Formulation Development & CDMO Services

    Product Global Customized Formulation Development & CDMO Services

    Dasan Pharmaceutical is a premier, technology-driven CDMO partner offering seamless, end-to-end solutions from initial formulation R&D to commercial-scale manufacturing. Powered by our proprietary oral drug delivery system (DDS) platforms, we provide globally compliant, customized development services ...
  • Duloxetine HCl EC Pellets

    Product Duloxetine HCl EC Pellets

    Duloxetine HCl EC Pellets are premium-quality enteric-coated pellets developed utilizing Dasan Pharmaceutical's advanced fluid-bed coating technology. Designed as a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), this product provides highly stable and controlled drug release, effectively preventi...